Articles Tagged With:
-
HIC at 50: Looking Back, Looking Forward in a Time of Pandemic
In Hospital Infection Control & Prevention's 50th year of publication, we find ourselves in a perilous world, where the emergence of viral infections and antibiotic-resistant organisms seems to be accelerating.
-
Timeline: Key Stories and Topics in HIC This Century
A look back at infection control and prevention topics in HIC over the last two decades.
-
Under-Resourced Public Health Leaves Healthcare Vulnerable
Allison McGeer, MD, an infectious disease specialist in the Sinai Health System and a professor at the University of Toronto, was on the front lines when SARS-1 hit the city in 2003. Hospital Infection Control & Prevention asked her about emerging infections and other issues in this interview.
-
OSHA Draft COVID-19 Rule in Healthcare Expected Soon
As this report was filed, the Occupational Safety and Health Administration (OSHA) had finalized the COVID-19 draft standard to protect healthcare workers and submitted it to the White House. On Dec. 8, 2022, OSHA sent the standard to the Office of Management and Budget, with a decision on its fate expected sometime in early 2023.
-
‘Vast Majority’ of Mild SARS-CoV-2 Cases Clear Long COVID by One Year
A recent Israeli study tries to deflate the haunting specter of long COVID by examining the association of mild SARS-CoV-2 infection and long-term health outcomes.
-
RSV Bronchiolitis Has Persisting Consequences for Some Children
Young children hospitalized with respiratory syncytial virus (RSV) infection are at increased risk of subsequent hospitalization during the following year and of increased need for outpatient healthcare.
-
A Comparison of Ceftaroline and Daptomycin in Treatment of MRSA Bloodstream Infections
Ceftaroline is an acceptable alternative therapy for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
-
An Effective Oral Regimen for Rifampin-Resistant Tuberculosis
A multicenter, randomized, controlled, noninferiority clinical trial found a 24-week, all-oral regimen (bedaquiline, pretomanid, linezolid, and moxifloxacin) to be safe and effective for patients aged 15 years and older with rifampin-resistant tuberculosis.
-
COVID Is Not ‘Just the Flu’
Among hospitalized patients requiring oxygen support at admission, COVID-19 was three times more fatal than was influenza.
-
Inching Toward the Goal: Does Selective Decontamination of the Digestive Tract Have a Benefit for Patients on Mechanical Ventilation?
Two recent articles contribute to the ongoing discussion of whether selective decontamination of the digestive tract provides a mortality benefit for patients who are receiving mechanical ventilation.